- $45.62bn
- $52.65bn
- $57.09bn
- 65
- 58
- 100
- 86
R2019 December 31st | R2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 41,541 | 41,909 | 50,601 | 51,411 | 57,094 |
Losses, Benefits, and Adjustments | |||||
Amortization of Policy Acquisition Costs | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 36,098 | 35,107 | 44,135 | 53,241 | 57,442 |
Operating Profit | 5,443 | 6,802 | 6,466 | -1,830 | -348 |
Net Income Before Taxes | 5,443 | 6,802 | 6,466 | -1,830 | -348 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4,327 | 5,429 | 5,174 | -1,342 | -213 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 4,847 | 5,576 | 1,614 | -1,289 | -188 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4,678 | 5,461 | 1,500 | -1,394 | -316 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 12.8 | 19.9 | 17.6 | -5.02 | -0.775 |
Dividends per Share |